Technology
Stereotaxis’s suite of proprietary magnetic coronary guidewires including CRONUS, ASSERT and TITAN, suitable for use in ...
August 27, 2008
Technology
The Pie Medical Imaging CAAS (Cardiovascular Angiography Analysis System) QCA 3D software offers automated detection and 3D analysis of single and bifurcated coronary arteries from angiographic X-ray projection images. Out-of-plane magnification and foreshortening errors are reportedly minimized by calculating true geometric shape in 3D space from two or more 2D X-ray projections.
August 27, 2008News
August 28, 2008 - Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC today launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disea
August 27, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025Technology
Genesis Medical Interventional Inc. developed the F.A.S.T. Funnel Catheter line of proximal occlusion funnel catheters for embolic protection.
August 27, 2008
Technology
The BRANSIST safire VC17 ceiling-mounted vascular package is a digital angiography system that features a 17 by 17-inch direct-conversion FPD, reportedly the largest in its class. The system is designed with not only high image quality, but also the optimal image quality for the various complex interventional procedures over the extensive field of views available.
August 27, 2008Technology
Terumo Interventional Systems will feature its Runthrough NS coronary guidewire at TCT 2008. The Runthrough NS ...
August 26, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
August 27, 2008 - XDx Inc. said today it received market clearance from the FDA for AlloMap Molecular Expression Testing ...
August 26, 2008Technology
Stentys, a French-based company, will feature its bifurcated stent at TCT 2008. The patent-pending bifurcated stent is ...
August 26, 2008News
August 27, 2008 - Stereotaxis Inc. announced yesterday the FDA clearance of its magnetically tipped PowerAssert ...
August 26, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
August 27, 2008 - The Children's Hospital at Montefiore (CHAM) in the Bronx recently received approval as a pediatric heart transplant center by the New York State Department of Health. On the strength of a newly recruited pediatric cardiology team, specialists at CHAM can now treat any congenital or acquired heart abnormality in children and adolescents.
August 26, 2008Technology
ProSolv CardioVascular, a FUJIFILM company, recently released ProSolv CardioVascular 4.0, a new software release ...
August 26, 2008News
Aug. 27, 2008 — Electrocardiographically gated 64-multidetector row coronary computed tomographic angiography (CCTA) was ...
August 26, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
August 27, 2008 - Cordis Corp. today said it received CE mark approval to market the CYPHER SELECT Plus Sirolimus ...
August 26, 2008Technology
Medtronic Inc. will showcase its Export Aspiration Catheter at TCT 2008. Recent results from an independent study, called TAPAS, showed that thrombus aspiration with the Export Aspiration Catheter prior to stenting can improve blood flow and survival rates in patients suffering acute myocardial infarction (AMI) compared to treatment with percutaneous coronary intervention (PCI) alone.
August 25, 2008News
August 26, 2008 - Anthera Pharmaceuticals Inc. yesterday announced the initiation of the FRANCIS (Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression) clinical trial to examine the impact of varespladib when administered to patients within 96 hours of an acute coronary syndrome (ACS) event.
August 25, 2008